DrugPatentWatch Database Preview
Details for Patent: 9,192,608
Which drugs does patent 9,192,608 protect, and when does it expire?
Patent 9,192,608 protects MORPHINE SULFATE and is included in one NDA.
This patent has eight patent family members in six countries.
Summary for Patent: 9,192,608
| Title: | Morphine formulations |
| Abstract: | Provided herein, generally, are pharmaceutical formulations, e.g., injectable pharmaceutical formulations with improved stability, comprising morphine sulfate or a hydrate thereof, and methods of producing and using the same. Also provided herein are kits comprising the formulations, e.g., injectable morphine formulations. |
| Inventor(s): | Cuine; Alain (St. Fargeau-Ponthierry, FR), Hoarau; Didier (Claix, FR), Romain; Pauline (Saint Egreve, FR) |
| Assignee: | BECTON DICKINSON FRANCE S.A.S. (Le Pont de Claix, FR) |
| Application Number: | 14/715,277 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; |
Drugs Protected by US Patent 9,192,608
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Usa | MORPHINE SULFATE | morphine sulfate | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 204223-001 | Oct 30, 2013 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | TREATMENT OF PAIN | ➤ Sign Up | ||||
| Fresenius Kabi Usa | MORPHINE SULFATE | morphine sulfate | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 204223-001 | Oct 30, 2013 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | MANAGEMENT OF CHRONIC PAIN IN PATIENTS REQUIRING OPIOID ANALGESIA | ➤ Sign Up | ||||
| Fresenius Kabi Usa | MORPHINE SULFATE | morphine sulfate | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 204223-002 | Oct 30, 2013 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | MANAGEMENT OF CHRONIC PAIN IN PATIENTS REQUIRING OPIOID ANALGESIA | ➤ Sign Up | ||||
| Fresenius Kabi Usa | MORPHINE SULFATE | morphine sulfate | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 204223-002 | Oct 30, 2013 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | TREATMENT OF PAIN | ➤ Sign Up | ||||
| Fresenius Kabi Usa | MORPHINE SULFATE | morphine sulfate | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 204223-003 | Oct 30, 2013 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | TREATMENT OF PAIN | ➤ Sign Up | ||||
| Fresenius Kabi Usa | MORPHINE SULFATE | morphine sulfate | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 204223-003 | Oct 30, 2013 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | MANAGEMENT OF CHRONIC PAIN IN PATIENTS REQUIRING OPIOID ANALGESIA | ➤ Sign Up | ||||
| Fresenius Kabi Usa | MORPHINE SULFATE | morphine sulfate | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 204223-004 | Oct 30, 2013 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | TREATMENT OF PAIN | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
International Family Members for US Patent 9,192,608
| Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2014230834 | ➤ Sign Up | |||
| Canada | 2902343 | ➤ Sign Up | |||
| China | 104042565 | ➤ Sign Up | |||
| European Patent Office | 2968132 | ➤ Sign Up | |||
| European Patent Office | 3143988 | ➤ Sign Up | |||
| Japan | 2016512210 | ➤ Sign Up | |||
| Japan | 6215970 | ➤ Sign Up | |||
| Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
